Department of Biochemistry, Institute of Rheumatology, Warsaw, Poland.
Inflamm Res. 2010 Mar;59 Suppl 2:S253-5. doi: 10.1007/s00011-009-0144-1.
Conventional physiotherapy (electrotherapy, magnetic fields), kinesitherapy, and whole-body cryotherapy (plus kinesitherapy) are used to relieve pain and inflammation or to improve function in rheumatic diseases. The aim of this study was to investigate the effects of different physiotherapies and cryotherapy on biochemical blood parameters of patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
Twenty patients with RA and 17 patients with OA received whole-body cryotherapy at -140 to -160 degrees C for 2 to 3 min, once daily for 4 weeks. The second group of patients (24 with RA and 28 with OA) received conventional physiotherapy for 4 weeks. We measured the parameters of neutrophil activation (respiratory burst, calprotectin) and markers of cartilage metabolism [N-acetyl-beta-D-hexosaminidase (NAHase), ectonucleotide pyrophosphohydrolase (NTPPHase)] twice: before and 3 months after cryotherapy or physiotherapy.
We showed, for the first time, that cryotherapy significantly reduced (P < 0.001) histamine levels in the blood of patients with RA. The effect was long-lasting (for at least 3 months). The levels of blood histamine in patients with OA were not changed significantly. Cryotherapy also downregulated the respiratory burst of PMNs and NAHase activity and upregulated calprotectin levels and the activity of NTPPHase. However, these changes were not statistically significant. In contrast, there were no significant changes in histamine levels or the other biochemical parameters measured in groups of patients treated only with physiotherapy and kinesitherapy.
It may be concluded that the beneficial clinical effects of cryotherapy in RA patients are in part due to the action on the production, release, or degradation of histamine.
传统的物理疗法(电疗、磁场)、运动疗法和全身冷冻疗法(结合运动疗法)用于缓解疼痛和炎症,或改善风湿性疾病的功能。本研究旨在探讨不同的物理疗法和冷冻疗法对类风湿关节炎(RA)和骨关节炎(OA)患者生化血液参数的影响。
20 名 RA 患者和 17 名 OA 患者接受全身冷冻疗法,温度为-140 至-160 摄氏度,每次 2 至 3 分钟,每天 1 次,持续 4 周。第二组患者(24 名 RA 患者和 28 名 OA 患者)接受了 4 周的传统物理疗法。我们在两次测量了中性粒细胞激活(呼吸爆发、钙卫蛋白)和软骨代谢标志物(N-乙酰-β-D-氨基己糖苷酶(NAHase)、核苷酸焦磷酸水解酶(NTPPHase))的参数:冷冻治疗或物理治疗前和 3 个月后。
我们首次表明,冷冻疗法显著降低了 RA 患者血液中的组胺水平(P < 0.001)。这种效果是持久的(至少持续 3 个月)。OA 患者的血液组胺水平没有明显变化。冷冻疗法还下调了 PMN 的呼吸爆发和 NAHase 活性,并上调了钙卫蛋白水平和 NTPPHase 的活性。然而,这些变化没有统计学意义。相比之下,在仅接受物理治疗和运动疗法的患者组中,组胺水平或测量的其他生化参数没有显著变化。
可以得出结论,冷冻疗法对 RA 患者的有益临床效果部分归因于对组胺的产生、释放或降解的作用。